Skip to main content
logo
Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
1.060
+0.310 (41.33%)
Sep 8, 2026, 3:42 PM EST

Vaccinex Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.60.60.570.280.90.63
Revenue Growth
5.44%5.44%107.27%-69.44%44.00%19.50%
Gross Profit
-11.94-11.94-16-13.7-16.26-20.93
Operating Income
-18.74-18.74-22.89-19.91-22.49-28.33
Net Income
-18.63-18.63-20.25-19.82-22.38-28.85
Earnings Per Share
-8.88-8.88-43.68-98.05-163.80-322.50
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
1.111.111.546.398.5910.6
Total Debt
0.030.030.250.490.399.21
Net Cash (Debt)
1.081.081.295.918.21.39
Net Cash Growth
-15.99%-15.99%-78.19%-27.97%490.71%-50.00%
Net Cash Per Share
0.520.522.7829.2359.6815.52

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-16.19-16.19-21.38-19.07-25.3-28.65
Capital Expenditures
-0.02-0.02-0.07-0.1-0.03-0.29
Free Cash Flow
-16.21-16.21-21.45-19.17-25.33-28.94
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
------
Operating Margin
-3117.30%-3117.30%-4014.91%-7238.55%-2498.89%-4532.96%
Pretax Margin
-3100.50%-3100.50%-3552.81%-7205.45%-2486.67%-4616.16%
Profit Margin
-3100.50%-3100.50%-3552.81%-7205.46%-2486.67%-4616.16%
FCF Margin
-2696.84%-2696.84%-3762.46%-6972.00%-2814.44%-4629.92%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
3.344.3714.57116.8935.5974.14